Stay updated on Intratumoral G100 in NHL Clinical Trial
Sign up to get notified when there's something new on the Intratumoral G100 in NHL Clinical Trial page.

Latest updates to the Intratumoral G100 in NHL Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. Deleted the funding-lapse notice and the previous Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding lapse and ongoing operations; updated the page revision to v3.4.1 and removed the previous revision v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe changes are minor UI and metadata updates, including a Show glossary toggle, standardized labeling such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new version label 'Revision: v3.4.0' (replacing the older 'Revision: v3.3.4'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no study content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedFooter now displays Revision: v3.3.3 and the HHS Vulnerability Disclosure link and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedPublications section updated to say publications are automatically filled from PubMed, replacing the previous wording. A site revision tag 'Revision: v3.3.2' was added; the old text implying automatic generation by ClinicalTrials.gov and NCT numbers was removed.SummaryDifference0.1%

Stay in the know with updates to Intratumoral G100 in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral G100 in NHL Clinical Trial page.